Gaviscon Strawberry chewable tablets blister No. 16

Instructions for Gaviscon Strawberry chewable tablets blister No. 16

Composition

active ingredients: 1 tablet contains; 250 mg sodium alginate, 133.5 mg sodium bicarbonate, 80 mg calcium carbonate;

excipients: xylitol DC, mannitol (E 421), macrogol 20000, strawberry flavor, aspartame (E961), magnesium stearate, red iron oxide (E 172).

Dosage form

Chewable tablets.

Main physicochemical properties: flat, round tablets with beveled edges, pale pink in color, with small inclusions, with a strawberry smell; on one side of the tablet, a circle and a sword are embossed, on the other side, GS 250 is embossed.

Pharmacotherapeutic group

Drugs for the treatment of peptic ulcer and gastroesophageal reflux disease.

ATX code A02B X13.

Pharmacological properties

Pharmacodynamics

After oral administration, Gaviscon® strawberry tablets quickly begin to interact with gastric juice, forming a layer of alginic acid gel on its surface, which has a pH close to neutral and effectively coats the walls of the stomach, preventing the occurrence of gastroesophageal reflux. In gastroesophageal reflux, this layer, distributed over the surface of the stomach contents, rising to the esophagus, prevents its irritation.

Pharmacokinetics

The mechanism of action of the drug is physical and does not depend on the level of absorption into the systemic circulation. The drug is not absorbed and does not have a systemic effect.

Indication

Treatment of symptoms of gastroesophageal reflux disease, namely: heartburn; acid regurgitation; digestive disorders related to reflux, including during pregnancy.

Contraindication

Hypersensitivity to any of the components of the drug.

Interaction with other medicinal products and other types of interactions

Due to the presence of calcium carbonate, which acts as an antacid, at least 2 hours should elapse between taking Gaviscon® strawberry tablets and taking other medications, especially H2-antihistamines, tetracyclines, digoxin, fluoroquinolone, iron salts, ketoconazole, neuroleptics, thyroxine, penicillamine, beta-blockers (atenolol, metoprolol, propanolol), glucocorticoids, chloroquine and bisphosphonates.

Application features

Patients on a low-salt diet for kidney disease or congestive heart failure should be aware that 4 tablets of the drug contain 246 mg (10.6 mmol) of sodium. Caution should be exercised when treating patients with hypercalcemia and nephrocalcinosis, and recurrent formation of calcium-containing kidney stones, considering that 4 tablets of the drug contain 320 mg (3.2 mmol) of calcium carbonate. Since the drug contains aspartame, it cannot be prescribed to patients with phenylketonuria. In patients with very low levels of gastric acid, reduced efficacy may occur. If there is no improvement within 7 days, consult a doctor.

Use during pregnancy or breastfeeding

Gaviscon® Strawberry Tablets do not affect the course of pregnancy, intrauterine and postnatal development of the fetus/child. Given the presence of calcium carbonate, it is recommended to use the drug for the shortest possible time. The drug can be used by pregnant women and during breastfeeding.

The ability to influence the reaction speed when driving or working with other mechanisms

The drug does not affect the ability to drive vehicles and work with other mechanisms.

Method of administration and doses

Adults and children over 12 years of age should take 2–4 tablets orally after meals and before bedtime (up to 4 times a day). The tablets should be chewed. The drug should not be used for more than 7 days. If the symptoms of the disease persist or worsen during this period, the patient should consult a doctor to clarify the diagnosis and adjust the treatment regimen. There is no need to adjust the dose for elderly patients.

Children. The drug is contraindicated for children under 6 years of age. Children under 12 years of age should only use the drug as directed and under the supervision of a physician.

Overdose

Overdose is very rare and may manifest as a feeling of bloating. In case of overdose, it is necessary to stop using the drug and carry out symptomatic therapy.

Adverse reactions

Very rarely, but as with the use of other medicines, patients with hypersensitivity to the components of the drug may experience an allergic reaction in the form of urticaria, bronchospasm, anaphylactic and anaphylactoid reactions. Abdominal bloating, constipation are possible.

Expiration date

2 years.

Storage conditions

Store at a temperature not exceeding 25 °C in the original packaging. Keep out of the reach of children.

Packaging

8 chewable tablets in a blister, 2 or 3 blisters in a cardboard box.

Vacation category

Without a prescription.

Producer

Location of the manufacturer and its business address

Dansom Lane, East Yorkshire, Hull, HU8 7DS, United Kingdom/Dansom Lane, East Yorkshire, Hull , HU8 7DS , United Kingdom .